Ministry of Health and Family Welfare
Record highest single day recoveries of 56,110 registered
India’s Recovery rate soars past 70%
India tests highest ever single day tests at 7,33,449
Posted On: 12 AUG 2020 2:58PM by PIB Delhi
The record highest single day recoveries at 56,110
registered in the last 24 hours are the result of the successful implementation
of effective containment strategy, aggressive and comprehensive testing coupled
with standardized clinical management of the critical patients based on
holistic Standard of Care approach.
The coordinated efforts of the Centre and State/UT
governments have resulted in continuously increasing average daily recoveries.
In the first week of July the daily average recovered cases were at 15000 which
jumped to more than 50000 in the first week of August.
With more patients recovering and being discharged from
hospitals and home isolation (in case of mild and moderate cases), the total
recoveries have crossed the 16 lakh mark to 16,39,599. The Recovery Rate has
reached another high of 70.38%.
The actual case load of the country is the active cases
(6,43,948) which is only 27.64% of the total positive cases. They are under
active medical supervision. With a consistent and sustained increase in
recoveries, the gap between recovered patients and active COVID-19 cases has
reached nearly 10 lakh.
Focus on improved and effective clinical treatment in
hospitals, use of non-invasive, improved and coordinated services of the
ambulances for ferrying patients for prompt and timely treatment have resulted
in seamless efficient patient management of COVID-19 patients. As a result, the
Case Fatality Rate (CFR) has been low when compared to the global average. It
is currently standing at 1.98%.
India's TEST, TRACK, TREAT strategy has achieved another
peak with 7,33,449 tests done in the last 24 hours. This has taken the
cumulative tests to more than 2.6 crore. The TPM has jumped to 18,852.
The graded and evolving response has resulted in a
testing strategy that steadily widened the testing net in the country. To keep
up with this strategy, the testing lab network in the country is continuously
strengthened which as on today consists of 1421 labs in the country; 944 labs
in the government sector and 477 private labs. These include:
•
Real-Time RT PCR based testing labs: 724 (Govt: 431 + Private: 293)
•
TrueNat based testing labs: 584 (Govt: 481 + Private: 103)
•
CBNAAT based testing labs: 113 (Govt: 32 + Private: 81)
For all authentic & updated information on COVID-19
related technical issues, guidelines & advisories please regularly visit:
https://www.mohfw.gov.in/ and @MoHFW_INDIA.
Technical queries related to COVID-19 may be sent to
technicalquery.covid19@gov.in and other queries on ncov2019@gov.in and
@CovidIndiaSeva .
In case of any queries on COVID-19, please call at the
Ministry of Health & Family Welfare helpline no.: +91-11-23978046 or 1075
(Toll-free). List of helpline numbers of States/UTs on COVID-19 is also
available at https://www.mohfw.gov.in/pdf/coronvavirushelplinenumber.pdf.
****
MV/SG
HFW/COVID Updates/12thAugust2020/1
(Release ID: 1645305) Visitor Counter : 233
Ministry of Health and Family Welfare
National Expert Group on Vaccine Administration for
COVID-19 deliberates on strategy to ensure COVID-19 vaccines’ availability and
its delivery mechanism
Posted On: 12 AUG 2020 5:28PM by PIB Delhi
National Expert Group on Vaccine Administration for
COVID-19, met for the first time on 12th August. The meeting was chaired by Dr V K Paul,
Member Niti Aayog along with Secretary (Ministry of Health and Family Welfare)
as co-Chair.
The expert group deliberated on conceptualization and
implementation mechanisms for creation of a digital infrastructure for
inventory management and delivery mechanism of the vaccine including tracking
of vaccination process with particular focus on last mile delivery. They
discussed on broad parameters guiding the selection of COVID-19 vaccine
candidates for the country and sought inputs from Standing Technical
Sub-Committee of National Technical Advisory Group on Immunization (NTAGI). The
group delved on the procurement mechanisms for COVID-19 vaccine, including both
indigenous and international manufacturing along with guiding principles for
prioritization of population groups for vaccination.
The expert group discussed on the financial resources
required for procurement of COVID-19 vaccine and various options of financing
the same. Available options in terms of delivery platforms, cold chain and
associated infrastructure for roll out of COVID-19 vaccination were also taken
up. Further, strategy and follow-up action on all possible scenarios to ensure
equitable and transparent delivery of vaccine was deliberated upon. Issues
related to vaccine safety and surveillance were taken up and strategy for
community involvement through transparent information and awareness creation
were discussed.
India’s support to its key neighbors and development
partner countries for COVID-19 vaccines was deliberated upon. The expert group
discussed that India will leverage domestic vaccine manufacturing capacity and
will also engage with all international players for early delivery of vaccines
not only in India but also in low and middle income countries.
The Committee also advised all the States not to chart
separate pathways of procurement.
****
MV/SG
HFW/COVID Vaccine/12thAugust2020/2
(Release ID: 1645363) Visitor Counter : 562
No comments:
Post a Comment